Back to search

Article

Inhibition of p107 alleviates liver steatosis by reducing de novo fatty acid synthesis

2026-04-16

Abstract excerpt

Metabolic dysfunction–associated steatotic liver disease (MASLD) is characterized by excessive hepatic lipid accumulation driven by increased de novo lipogenesis (DNL) and impaired lipid oxidation. p107, a member of the retinoblastoma (Rb) family, extensively studied in the context of cell cycle regulation and adipocyte differentiation recently has been identified as a metabolic regulator controlling thermogenic a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0ee1a6e4-cedf-5944-be0a-cc7d0ff0b892
DOI
10.64898/2026.04.14.718271
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Inhibition of p107 alleviates liver steatosis by reducing de novo fatty acid synthesisDOI 10.64898/2026.04.14.718271
Select a neighboring publication to make it the new centre.